Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
83 hedge funds and large institutions have $36.1M invested in Avid Bioservices, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 17 closing their positions.
207% more call options, than puts
Call options by funds: $172K | Put options by funds: $56K
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
8% less funds holding
Funds holding: 90 → 83 (-7)
24% less capital invested
Capital invested by funds: $47.2M → $36.1M (-$11.1M)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$583K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$571K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$521K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$493K |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$417K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.46M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.08M |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$488K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$410K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$293K |
CDMO Hedge Fund Activity: Q3 2015 in Review
83 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2015, worth a combined $36.1M — down 24% from $47.2M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CDMO and 11 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 24 added.
The largest buyer was Millennium Management, adding an estimated $583K. The largest seller was Renaissance Technologies, cutting an estimated $1.46M.
- 83 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2015, down from 90 in Q2 2015.
- Funds reported $36.1M of Avid Bioservices, Inc. Common Stock stock for Q3 2015, down 24% quarter-over-quarter.
- 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2015 and 17 closed out, a net change of -6 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2015 was Millennium Management, an estimated $583K added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2015 was Renaissance Technologies, an estimated $1.46M sold.
Based on aggregated 13F filings for Q3 2015.